CAPTRUST FINANCIAL ADVISORS - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$17,000
-37.0%
1,700
-22.7%
0.00%
Q1 2022$27,000
-46.0%
2,2000.0%0.00%
Q4 2021$50,000
+2.0%
2,2000.0%0.00%
Q3 2021$49,000
+69.0%
2,2000.0%0.00%
Q2 2021$29,000
-47.3%
2,200
-47.6%
0.00%
-100.0%
Q1 2021$55,000
+83.3%
4,200
+90.9%
0.00%
Q4 2020$30,000
-6.2%
2,2000.0%0.00%
-100.0%
Q3 2020$32,000
-8.6%
2,2000.0%0.00%0.0%
Q2 2020$35,000
+191.7%
2,2000.0%0.00%
Q3 2019$12,000
-14.3%
2,2000.0%0.00%
-100.0%
Q2 2019$14,0000.0%2,2000.0%0.00%0.0%
Q1 2019$14,0002,2000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 188,500$4,311,0003.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 334,500$7,647,0001.70%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,760$3,013,0001.49%
NEA Management Company, LLC 3,069,834$70,207,0001.42%
Berry Street Capital Management LLP 575,000$13,151,0001.36%
Melqart Asset Management (UK) Ltd 916,321$20,956,0001.06%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$2,287,0000.93%
HighMark Wealth Management LLC 50,499$1,155,0000.73%
Artal Group S.A. 1,000,000$22,870,0000.62%
Vigilare Wealth Management 34,925$799,0000.47%
View complete list of AURINIA PHARMACEUTICALS INC shareholders